TY - JOUR
T1 - Mitochondrial respiration supports autophagy to provide stress resistance during quiescence
AU - Magalhaes-Novais, Silvia
AU - Blecha, Jan
AU - Naraine, Ravindra
AU - Mikesova, Jana
AU - Abaffy, Pavel
AU - Pecinova, Alena
AU - Milosevic, Mirko
AU - Bohuslavova, Romana
AU - Prochazka, Jan
AU - Khan, Shawez
AU - Novotna, Eliska
AU - Sindelka, Radek
AU - Machan, Radek
AU - Dewerchin, Mieke
AU - Vlcak, Erik
AU - Kalucka, Joanna
AU - Stemberkova Hubackova, Sona
AU - Benda, Ales
AU - Goveia, Jermaine
AU - Mracek, Tomas
AU - Barinka, Cyril
AU - Carmeliet, Peter
AU - Neuzil, Jiri
AU - Rohlenova, Katerina
AU - Rohlena, Jakub
PY - 2022/10
Y1 - 2022/10
N2 - Mitochondrial oxidative phosphorylation (OXPHOS) generates ATP, but OXPHOS also supports biosynthesis during proliferation. In contrast, the role of OXPHOS during quiescence, beyond ATP production, is not well understood. Using mouse models of inducible OXPHOS deficiency in all cell types or specifically in the vascular endothelium that negligibly relies on OXPHOS-derived ATP, we show that selectively during quiescence OXPHOS provides oxidative stress resistance by supporting macroautophagy/autophagy. Mechanistically, OXPHOS constitutively generates low levels of endogenous ROS that induce autophagy via attenuation of ATG4B activity, which provides protection from ROS insult. Physiologically, the OXPHOS-autophagy system (i) protects healthy tissue from toxicity of ROS-based anticancer therapy, and (ii) provides ROS resistance in the endothelium, ameliorating systemic LPS-induced inflammation as well as inflammatory bowel disease. Hence, cells acquired mitochondria during evolution to profit from oxidative metabolism, but also built in an autophagy-based ROS-induced protective mechanism to guard against oxidative stress associated with OXPHOS function during quiescence.Abbreviations: AMPK: AMP-activated protein kinase; AOX: alternative oxidase; Baf A: bafilomycin A1; CI, respiratory complexes I; DCF-DA: 2',7'-dichlordihydrofluorescein diacetate; DHE: dihydroethidium; DSS: dextran sodium sulfate; ΔΨmi: mitochondrial inner membrane potential; EdU: 5-ethynyl-2'-deoxyuridine; ETC: electron transport chain; FA: formaldehyde; HUVEC; human umbilical cord endothelial cells; IBD: inflammatory bowel disease; LC3B: microtubule associated protein 1 light chain 3 beta; LPS: lipopolysaccharide; MEFs: mouse embryonic fibroblasts; MTORC1: mechanistic target of rapamycin kinase complex 1; mtDNA: mitochondrial DNA; NAC: N-acetyl cysteine; OXPHOS: oxidative phosphorylation; PCs: proliferating cells; PE: phosphatidylethanolamine; PEITC: phenethyl isothiocyanate; QCs: quiescent cells; ROS: reactive oxygen species; PLA2: phospholipase A2, WB: western blot.
AB - Mitochondrial oxidative phosphorylation (OXPHOS) generates ATP, but OXPHOS also supports biosynthesis during proliferation. In contrast, the role of OXPHOS during quiescence, beyond ATP production, is not well understood. Using mouse models of inducible OXPHOS deficiency in all cell types or specifically in the vascular endothelium that negligibly relies on OXPHOS-derived ATP, we show that selectively during quiescence OXPHOS provides oxidative stress resistance by supporting macroautophagy/autophagy. Mechanistically, OXPHOS constitutively generates low levels of endogenous ROS that induce autophagy via attenuation of ATG4B activity, which provides protection from ROS insult. Physiologically, the OXPHOS-autophagy system (i) protects healthy tissue from toxicity of ROS-based anticancer therapy, and (ii) provides ROS resistance in the endothelium, ameliorating systemic LPS-induced inflammation as well as inflammatory bowel disease. Hence, cells acquired mitochondria during evolution to profit from oxidative metabolism, but also built in an autophagy-based ROS-induced protective mechanism to guard against oxidative stress associated with OXPHOS function during quiescence.Abbreviations: AMPK: AMP-activated protein kinase; AOX: alternative oxidase; Baf A: bafilomycin A1; CI, respiratory complexes I; DCF-DA: 2',7'-dichlordihydrofluorescein diacetate; DHE: dihydroethidium; DSS: dextran sodium sulfate; ΔΨmi: mitochondrial inner membrane potential; EdU: 5-ethynyl-2'-deoxyuridine; ETC: electron transport chain; FA: formaldehyde; HUVEC; human umbilical cord endothelial cells; IBD: inflammatory bowel disease; LC3B: microtubule associated protein 1 light chain 3 beta; LPS: lipopolysaccharide; MEFs: mouse embryonic fibroblasts; MTORC1: mechanistic target of rapamycin kinase complex 1; mtDNA: mitochondrial DNA; NAC: N-acetyl cysteine; OXPHOS: oxidative phosphorylation; PCs: proliferating cells; PE: phosphatidylethanolamine; PEITC: phenethyl isothiocyanate; QCs: quiescent cells; ROS: reactive oxygen species; PLA2: phospholipase A2, WB: western blot.
KW - AMP-Activated Protein Kinases/metabolism
KW - Adenosine Triphosphate/metabolism
KW - Animals
KW - Autophagy
KW - Cysteine/metabolism
KW - DNA, Mitochondrial/metabolism
KW - Dextrans/metabolism
KW - Endothelial Cells/metabolism
KW - Fibroblasts/metabolism
KW - Formaldehyde/metabolism
KW - Humans
KW - Inflammatory Bowel Diseases/metabolism
KW - Isothiocyanates
KW - Lipopolysaccharides/metabolism
KW - Mechanistic Target of Rapamycin Complex 1/metabolism
KW - Mice
KW - Microtubule-Associated Proteins/metabolism
KW - Mitochondria/metabolism
KW - Phosphatidylethanolamines/metabolism
KW - Reactive Oxygen Species/metabolism
KW - Respiration
KW - Sirolimus
UR - http://www.scopus.com/inward/record.url?scp=85126384039&partnerID=8YFLogxK
U2 - 10.1080/15548627.2022.2038898
DO - 10.1080/15548627.2022.2038898
M3 - Journal article
C2 - 35258392
SN - 1554-8627
VL - 18
SP - 2409
EP - 2426
JO - Autophagy
JF - Autophagy
IS - 10
ER -